Table 3.
Variables | No | % | Exp(B) (95% CI) | P |
---|---|---|---|---|
age | 0.997(0.958~1.038) | 0.893 | ||
median | 55 | |||
staging | 0.878 | |||
Ⅰ+Ⅱ | 18 | 20.2% | 1 | |
Ⅲ+Ⅳ | 71 | 79.8% | 1.102 (0.320~3.799) | |
GOG performance status | 0.785 | |||
0-1 | 74 | 83.2% | 1 | |
2-3 | 15 | 16.8% | 1.235 (0.768-2.576) | |
histology | 0.096 | |||
serious | 62 | 69.7% | 1 | |
Mucinous+clear cell | 10 | 11.2% | 3.429 (0.867~13.562) | 0.079 |
other | 17 | 19.1% | 0.457(0.093~2.244) | 0.335 |
grade | 0.352 | |||
1 | 12 | 13.5% | 1 | |
2 | 27 | 30.3% | 0.857(0.175~4.206) | 0.849 |
3 | 42 | 47.2% | 0.706(0.155~3.217) | 0.653 |
Not available | 8 | 9.0% | 3.000(0.447~20.153) | 0.258 |
Residual tumor | 0.000 | |||
≤1cm | 69 | 77.5% | 1 | |
>1cm | 20 | 22.5% | 7.211 (2.384~21.814) | |
Serum annexin A3 level (ng/mL) | 0.004 | |||
median | 1.20 | 1.849(1.214~2.814) |